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Background: PrPSc, the only known constituent of prions, the infectious agents causing prion diseases, can be
detected by real-time quaking-induced conversion (RT-QuIC). However, there is no efficient method to quantify the
amount of PrPSc by RT-QuIC.
Results: Here we introduce quantitative RT-QuIC (qRT-QuIC) to quantify with high accuracy minute amounts of
PrPSc in the brain and various peripheral tissues at levels far below detection by in vivo transmission. PrPSc is
relatively resistant to treatment with proteinase K (PK). However, as there can also be a fraction of pathological PrP
that is digested by PK, we use the term PrP27-30 to denote to the amount of PrPSc that can be detected by
immunoblot after PK treatment. qRT-QuIC is based upon the quantitative correlation between the seeded amount
of PrP27-30 and the lag time to the start of the conversion reaction detected by RT-QuIC. By seeding known
amounts of PrP27-30 quantified by immunoblot into qRT-QuIC a standard calibration curve can be obtained. Based
on this calibration curve, seeded undetermined amounts of PrP27-30 can be directly calculated. qRT-QuIC allowed to
quantify PrP27-30 concentrations at extremely low levels as low as 10-15.5 g PrP27-30, which corresponds to 0.001 LD50
units obtained by in vivo i.c. transmission studies. We find that PrP27-30 concentration increases steadily in the brain
after inoculation and can be detected at various time points during the incubation period in peripheral organs
(spleen, heart, muscle, liver, kidney) in two experimental scrapie strains (RML, ME7) in the mouse.
Conclusions: We suggest that an automatic quantitative system to measure disease progression as well as prion
contamination of organs, blood and food product is feasible. Moreover, the concept of qRT-QuIC should be
applicable to measure other disease-associated proteins rich in β-pleated structures (amyloid) that bind ThT and
that show seeded aggregation.
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Prion diseases are a group of transmissible neurodege-
nerative lethal disorders in humans, cattle, sheep, elk,
mink and experimental animals. These diseases are cha-
racterized by neuronal death and the accumulation of
pathological disease-associated prion protein (PrPSc) in
the central nervous system [1]. PrPSc is thought to be
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reproduction in any medium, provided the ortransmissible agent, or prion. Prion propagation seems to
rely on autocatalytic amplification of PrPSc by converting
the host-encoded cellular prion protein (PrPC) to the
pathogenic PrPSc form without the participation of nucleic
acids [2,3]. The conversion of PrPC to PrPSc is a post-
translational event and involves a conformational change
of the protein [4,5]. To distinguish between PrPSc which is
isolated from infectious tissue and is per definitionem as-
sociated with the TSE agent on the one hand and structu-
rally altered PrP, which has been converted into a
ProteinaseK-resistant form in vitro, on the other, we refer. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Shi et al. Acta Neuropathologica Communications 2013, 1:44 Page 2 of 9
http://www.actaneurocomms.org/content/1/1/44to the latter as ‘PrPres’. The most commonly used
approach to distinguish PrPSc from PrPC when analyzing
infected tissues is based on pre-treatment with proteinase
K as PrPSc is relatively PK-resistant. However, as there can
also be a fraction of pathological PrP that is digested by
PK treatment [6], we use the term PrP27-30 [2] in this
manuscript whenever we refer to the amount of PK-
resistant PrPSc that can be detected by immunoblotting.
The infectivity of prions presents a serious risk to
human health. One important issue in prion research is
the sensitive detection and quantification of prions at
low levels during the incubation period and in peripheral
tissues to provide suitable detection assays for medicine
and bio safety. Real-time quaking-induced conversion
(RT-QuIC) was established to detect prion infectivity
with very high sensitivity from diluted brain [7], from
cerebrospinal fluid (CSF) of end-stage disease containing
only very low levels of infectivity [8-10], and from CSF
during the incubation period [11]. The mechanism of
RT-QuIC is based upon the conversion of PK-sensitive
recombinant prion protein (rPrPsen) into a PK-resistant
rPrP (rPrPres) conformer, which is rich in β-sheet struc-
tures, by seeding the reaction mixture with PrPSc and
periodic shaking (Figure 1a). The correlation between
Thioflavin T (ThT) fluorescence and rPrPres has been
shown previously and is used to monitor the conversion
in a real-time curve [8].
Although protease-resistant PrP27-30 is often used as a
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Figure 1 The basis of amplifying PrPSc with RT-QuIC. (a) Schematic illu
increasing the total amount of β-sheeted PrP. This increase can be demons
sample containing PrPSc (prion) is distinguished from that without PrPSc (no
amount of newly formed rPrPres but the time to reach the steep increase
quantity of PK-treated PrPSc (PrP27-30). Different amounts of purified mouse
reactions to perform 80 hours of RT-QuIC. PrPC did not cause ascendant cuof infectivity measured by inoculation in experimental
animals does not always fully correlate with the amount
of PrP27-30 detected by immunoblot. The correlation of
the seeding activity on rPrPsen conversion into rPrPres
measured by RT-QuIC with the amount of PrP27-30 is
also a complex issue. For example, it has been shown
that vCJD prions have less seeding activity than sCJD
prions despite the relatively high PrP27-30 concentration
[10], and that prions from brains of 263 K-affected mice
with little immunoblot-detectable PrP27-30 have a seeding
activity comparable to that associated with the high-PrPSc
strain, 139A [12]. In previous studies, we showed that the
complex correlation between amounts of PrP27-30 and
infectivity in vivo and seeding activity in vitro can be
explained at least in part by differences in size distribution
of PrP aggregates [13]. Consequently, RT-QuIC seeding
activity may correlate more closely with prion infectivity
than with PrP27-30 levels, which can be considered an
advantage in regard to the development of assays for prion
detection.
We observed that in the RT-QuIC reaction, adding
small amounts of PrPSc resulted in a delayed initiation of
conversion detected by ThT fluorescence (Figure 1b).
This delay and the shape of the resulting ThT fluores-
cence curve appeared similar to the kinetics of amplifi-
cation of DNA that is used for quantitative RT-PCR
analysis [14,15]. Thus we investigated whether real-time
protein amplification was quantitative and established a


















stration of RT-QuIC. PrPSc converts rPrPsen to rPrPres thereby
trated by the increased value of ThT-fluorescence. Therefore, the
n-prion). RFU, relative fluorescence units. (b) However, it was not the
of amplification (ascendant curves) that was related to the seeded
RML scrapie-prion PrP27-30 and normal mouse PrPC were seeded into
rves.
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suring lag time of detectable conversion. We termed this
approach qRT-QuIC and show that it allows quantita-
tion of prions in various tissues with a detection limit
corresponding to 0.001 LD50 units.
Results and discussion
Establishing quantitative RT-QuIC
To establish a high-throughput quantification system,
PrP27-30 derived from two mouse-adapted scrapie prion
strains, RML and ME7, was purified from infected
C57BL/6 mouse brain by repeated NaCl precipitation
allowing recovery of 97% of the total PrPSc [16]. The
concentration of protease-resistant PrPSc was estimated
by semi-quantitative immunoblotting and comparing
band intensities to reference samples containing known
quantities of rPrPsen [17] (data not shown). To estimate
the minimum amount of PrP27-30 equivalent that can
start the seeding reaction, we serially diluted PrP27-30
(from 10-8 to 10-11.5 g) (Figure 2a). 10-9.5 g of both RML
and ME7 PrP27-30 were visible as a faint band on the im-
munoblot while 10-10 g was not detectable. As the con-
trol, PrPC from healthy C57BL/6 mouse brain was
purified [18] and quantified as above. For controlling
the quality of the real-time curve, the ThT-binding
fluorescence of both PrP27-30 and PrPC was measured
(Figure 2b); the results showed that the fluorescence
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Figure 2 Directly detecting purified PrP27-30 with immunoblotting and
scrapie-prion PrP27-30 was serially diluted and detected by immunoblotting
loading on the gel. Undigested PrPC is shown as a migration control. Signa
right. (b) Fluorescence of purified RML and ME7 PrP27-30 and normal PrPC w
shown (n = 5).PrPC and the blank (no PrP). Since 10-10 g of PrP27-30
from both prion strains was undetectable in either
immunoblot or ThT-fluorescence, we chose it as the
initial seed.
To establish the quantitative RT-QuIC (qRT-QuIC),
the seeds containing 10-10 to 10-16 g of purified RML
and ME7 PrP27-30 and PrPC per 10 μl were prepared by
serial half-log (100.5-fold) dilution (a total of 39 samples).
Full-length mouse rPrPsen (amino acids 23–230) was
utilized as the substrate. To estimate the time-span of
the reaction, 130 h of RT-QuIC was tested for determin-
ing the appropriate duration. Spontaneous conversion
seemed to occur after 90 h (Additional file 1: Figure S1).
For standardizing the results, a ‘positive reaction’ of RT-
QuIC was recorded when the detected intensity of fluo-
rescence was equal or higher than a threshold. The
threshold was 3 times of the fluorescence of the initial
phase (0 h). The corresponding time (hours) required to
reach the threshold was recorded as the independent vari-
able (x), and the equivalent amount of seeded PrP27-30 was
the dependent variable (y), as shown in Figure 3a. Next,
RT-QuIC reactions seeded with 10-10 to 10-16 g of PrP27-30
and PrPC were performed up to 90 h (shown in Figure 3b
and Additional file 1: Figures S2 and S3). Five repeats of
RT-QuIC for each seeded amount of PrP27-30 and PrPC
equivalents (a total of 260 reactions) were tested. Reac-
tions seeded with 10-10 to 10-15.5 g of PrP27-30 were posi-














ThT-binding fluorescence. (a) Purified mouse RML and ME7
. Aliquots were digested with 100 μg/ml Proteinase K (PK) before
ls were detected by 4H11 monoclonal antibody. Mr is shown on the


























0 10 20 30 40 50 60 70 80 90
ME7
QuIC in hours









0 10 20 30 40 50 60 70 80 90
































0 10 20 30 40 50 60 70 80 90
QuIC in hours
initial                   
0 hour
required                 
hours (x)
initial              
RFU 







Figure 3 Establishing the quantitative RT-QuIC (qRT-QuIC). (a) Schematic illustration of qRT-QuIC. The PrP27-30 propagating duration (hour)
required to reach the threshold which was at least 3 times the starting fluorescence was set as the independent variable (x), the correlated
seeded amount of PrP27-30 was the dependent variable (y). (b) Different amounts of purified PrP27-30 (10-10 to 10-16 g with serial 100.5-fold
dilution) were seeded into RT-QuIC reactions using mouse rPrPsen as the substrate. The RT-QuIC process was followed from 0 to 90 h by
showing the number of hours required to reach the threshold (indicated by black arrows and intersecting lines). Purified PrPC with identical
amounts was seeded in independent RT-QuIC reactions as control. Seeded amounts of both PrP27-30 and PrPC are indicated on the top right; see
also Additional file 1: Figures S2 and S3. (c) The results from five repeats of RT-QuIC seeded by PrP27-30 were provided to yield standard
calibration curves and formulas for quantification. This relates QuIC time necessary to reach the threshold to the amount of seeded PrP27-30. The
mean and s.e.m. are shown (n = 5).
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tions seeded with different amounts of PrPC did not show
spontaneous conversion up to 90 h. Therefore, the RT-
QuIC allowed detecting 10-15.5 g (≈ 0.32 fg) of PrP27-30,
which was 1 million times more sensitive than the immu-
noblot shown in Figure 1a. By analyzing the distribution
of the required hours mathematically using a standard
tool (Microsoft Excel), we obtained calibration curves and
derived two formulas for calculating the quantities of
seeded RML and ME7 PrP27-30 in the qRT-QuIC system
(Figure 3c).
Measuring PrP27-30 concentrations in brains and
peripheral organs at different dpi of prion infection
To see the feasibility of qRT-QuIC to determine the pro-
gression of prion disease, qRT-QuIC was used to meas-
ure PrP27-30 at different days post inoculation (dpi). 30,
60, 90, 120, 135, 150 and 170 dpi were chosen for RML,
30 to 150 dpi were chosen for ME7, since 170 dpi de-
notes the terminal stage of the RML strain while 150 dpi
is the terminal stage of the ME7 strain. Groups of each 5
C57BL/6 mice were inoculated intracerebrally and the
brains and peripheral tissues (heart, liver, spleen, lung,
kidney and hind-limb muscle) were harvested at the dpi
indicated above. The tissues of age-related healthy
C57BL/6 mice were chosen as controls (n = 5 for each
dpi). 10 mg of each tissue were treated with the method
of purifying PrP27-30 for obtaining tissue extracts as the
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Figure 4 Quantification of RML and ME7 PrP27-30 in brain at various d
at was analyzed by immunoblotting after digestion with 100 μg/ml PK. PrP
monoclonal antibody. Mr is shown on the right. (b) Comparing PrP
27-30 con
immunoblot. The brains of RML-inoculated mice 90 dpi to 170 dpi and ME
of immunobloting to detect PrP27-30 from the time-point not earlier than 9
by using detecting methods and time-points as the variables. Shown dataimportant to remove potential components affecting RT-
QuIC efficiency. Since the PrP27-30 level is much higher
in the brain than in other organs, 1 mg of brain from
infected mice of different time-points was first analyzed
by immunoblotting for obtaining an overview of the
presence of PrP27-30 (Figure 4a). By immunoblotting,
neither in RML nor in ME7 was PrP27-30 detectable at
30 and 60 dpi, in both strains PrP27-30 first appeared at
90 dpi and showed a steady increase to the terminal
stage. For the preparation of RT-QuIC seeds, the brain
extracts of 90 to 170 dpi of the brain were diluted 104-
fold, and those of the spleen and muscle were diluted
10-fold. Before measuring PrP27-30 concentrations in
peripheral organs, a comparison was done to estimate
the reliability of qRT-QuIC (Figure 4b). The results
showed that PrP27-30 concentrations in the brains obtained
from qRT-QuIC were comparable to those from quantita-
tive immunoblottings at different time points after inocu-
lation (see also in Additional file 1: Table S1), indicating
that qRT-QuIC is suited to measure the PrP27-30
concentrations.
After 90 h of amplification we calculated the concentra-
tion of PrP27-30 equivalents based on the detected seeding
activity by using the formulas in Figure 3c. The levels of
PrP27-30 equivalents (i.e. seeding activity) in the brain
showed the expected increasing tendency (Figure 5). In
particular, seeding activity reached the highest levels at
170 dpi in the RML strain and 150 dpi in the ME7 strain.
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ays post infection (dpi). (a) 1 mg of brain from scrapie-infected mice
C is shown as a migration control. Signals were detected by 4H11
centrations measured by quantitative RT-QuIC and quantitative
7-inoculated mice 90 to 150 dpi were chosen regarding the capacity
0 dpi. The significance (p value) was calculated with two-way ANOVA

































   




































Figure 5 The seeding activity (expressed as PrP27-30 equvalents in g/g tissue) in various tissues from different time-points after
inioculation were measured by qRT-QuIC by using the formulas shown in Figure 3c. The PrP27-30 concentration corresponding to 1 LD50
units per gram of tissue is represented by a gray broken line. Shown are the mean and s.e.m. (n = 5).
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but the signals from the heart started to show at 135 dpi
in the RML strain and 120 dpi in the ME7 strain, while
those from muscle were positive starting at 120 dpi of
the RML strain and 90 dpi of ME7. Interestingly,
seeding activity in the liver and kidney in the RML
strain was detectable in early stages (30 and 60 dpi), and
disappeared during the intermediate stages of infection
(90, 120 and 135 dpi), whereas those of ME7-infection
were continuously negative till 135 dpi. Seeding activity
in the spleen of both prion strains was decreasing at
early stages followed by an increase in the intermediate
stages. The concentration of PrP27-30 equivalents in all
three tissues was increased at late to final stages. No
seeding activity was detected in the lungs at any time.
Since qRT-QuIC was 1 million times more sensitive
than normal immunoblotting, these results suggest a
possibility of using qRT-QuIC to track disease progres-
sion or analyze prion propagation in various tissues.
To demonstrate the feasibility of qRT-QuIC in the
assessment of bio-hazard risks, the concentration of
PrP27-30/g tissue (g/g) in various tissues measured by
qRT-QuIC was compared to the reported half-lethal
doses (LD50) of both prion strains. The known LD50 of
RML and ME7 are 10-8.8 and 10-8.3 g of terminal brains,
respectively [19]. Using the PrP27-30 concentration
measured by qRT-QuIC, we can roughly extrapolate
that 1 LD50 unit contained 10
-12.93 g of PrP27-30 for
RML and 10-12.72 g for ME7. One LD50 unit is shown as
the gray dotted lines in Figure 5 to indicate the extent of
prion concentration in each gram of tissue (see also
Additional file 1: Tables S2 and S3), suggesting that
qRT-QuIC can be used for estimating prion contami-
nation in biological materials. As our protocol uses an
extraction method for PrP27-30 prior to qRT-QuIC that
removes potentially interfering factors present in peri-
pheral tissues, the calibration curve obtained for brain-
derived PrP27-30 should also provide meaningful results
for other tissues from the same species. Moreover, ourfindings for RML and ME7 indicate that similar assay
conditions can be efficient for different strains. How-
ever, to ensure optimum sensitivity, the exact conditions
of the qRT-QuIC assay need to be established for differ-
ent species and strains.
In a recent study, Wilham and colleagues [7] used
SD50 (50% seeding dose) to quantify seeding activity in
the RT-QuIC. SD50 was defined as minimum seeded
amount causing 50% of RT-QuIC reactions to be posi-
tive. Using end-point titration in a dilution series for
quantification, SD50 was shown to correlate with the
infectivity of 263 K strains in hamster. To obtain SD50
values for one prion strain in RT-QuIC, serially diluted
standard sample are required, e.g., serially diluted prion-
infected reference brain homogenate and serially diluted
undetermined materials. Thus, this approach requires
multiple repeats to yield the percentage of positive reac-
tions for every dilution. In contrast, qRT-QuIC is a lag
time-based assay and the amount of PrP27-30 equivalents
in suspected materials can be directly calculated and
quantified with much fewer repeats based on the calibra-
tion curve. The respective advantages and disadvantages
of end-point titration and lag time assays are well known
from assays of prion infection in vivo. End-point titra-
tion provides an accurate measure of infectious units.
However, end-point in vivo assay also requires multiple
repeats for each dilution of seeds to obtain the titration
of one prion strain, whereas the incubation time in vivo
assay is more commonly used for prion quantification as
much less animals are required. Hence, we conclude that
the qRT-QuIC assay which uses lag time is more suitable
than SD50 measurements for quantitative detection and
high-throughput assay for prion diagnosis.
Conclusion
In conclusion, qRT-QuIC is a new advancement of the
RT-QuIC system, which enables us to quantify PrP27-30
concentrations at extremely low levels as low as 10-15.5 g
PrP27-30, which corresponds to 0.001 LD50 units. qRT-
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the seeded amount of PrP27-30 and the lag time to the
start of the conversion reaction detected by RT-QuIC.
The principle of generating standard curves by monitoring
the fluorescence and setting threshold levels makes qRT-
QuIC applicable to the development of an automatic
system similar to quantitative RT-PCR. qRT-QuIC can be
used as a rapid and reliable novel research tool, increase
the precision of diagnosis, and help to follow the effects of
therapy of prion diseases. Moreover, this concept should
be applicable to measure other proteins rich in β-pleated
structures (amyloids) that bind ThT and that show seeded
aggregation.Methods
rPrPsen expression and purification
BL21 (DE3) E.coli and pET41a system (Merk, Germany)
were used to express mouse rPrPsen. Bacteria were cul-
tured in LB medium at 37°C with 220 rpm shaking and
were added 1 mM of IPTG (final concentration) when
OD reached 0.7 to 0.9. The cell pellet was harvested by
10,000 g centrifugation at 4°C for 10 min after 4 hours in-
duction. Thereafter, cells were resuspended by BugBuster
Master Mix (Novagen, Germany) containing rLysozyme
and Benzonase for extracting inclusion bodies (manual for
BugBuster, Novagen, Germany). The extracted inclusion
bodies were denatured with 8 M Guanidine hydrochloride
at 25°C for 1 hour. The denatured protein solution was
centrifuged at 16,000 g at 4°C for 20 min to remove the
debris.
We chose Ni2+-NTA superflow (Qiagen, Germany)
resin for protein purification. The NTA resin was pre-
pared by following the manufacturer’s manual. The de-
natured protein was loaded onto prepared resin followed
by binding with inversion on the rotor at 25°C for 1 hour.
After that, the resin was loaded into the column (GE
healthcare, USA) followed by connecting to the AKTA
prime (GE healthcare, USA). The followed purification
procedures including refolding and elution were
performed as described [7].
After elution, the rPrPsen solution was loaded into
6 KDa Cellu Sep dialysis tubing (Interchim, France)
followed by immersion in pre-chilled dialysis buffer
(9 mM NaH2PO4, 1 mM Na2HPO4, pH 5.9) at 4°C.
The dialysis was done in 2 successive steps, which
were 2 hours and 18 hours, respectively. 100 volumes
of dialysis buffer were used for each step. The dia-
lyzed solutions were sterilized with a 0.22 μm filter
(Millipore, USA) and the absorption was measured at
280 nm for calculating the concentration of rPrPsen.
The concentration of each fraction was adjusted to
0.5 mg/ml by adding sterilized and chilled dialysis
buffer. The rPrPsen solution was aliquoted and frozenin liquid nitrogen, followed by transfer to a freezer
(−80°C) for long-term storage.
Tissue preparation
6-week old C57BL/6 mice were inoculated with mouse-
adapted RML and ME7 scrapie (i.c). 10 μl of 10% brain
homogenate in 1 × PBS (pH 7.2) was used for each
inoculum. 7 time-points (30, 60, 90, 120, 135, 150 and
170 dpi, days post inoculation) were set for RML-
infection and 6 time-points (30, 60, 90, 120, 135 and 150
dpi) were for ME7-infection. At each dpi, five mice were
sacrificed with CO2. To harvest the tissues (brain, heart,
liver, spleen, lung, kidney and hindlimb muscle) they
were washed with chilled 1 × PBS containing 5% sodium
citrate to remove the blood. Then tissues were weighed
and stored in liquid nitrogen. The tissues of age-related
control C57BL/6 mice were prepared following the same
procedure.
PrP27-30 purification
We followed a published protocol [16] to purify PrP27-30.
The RML- and ME7-infected mouse tissue was prepared
to 10% homogenate (w/v) with lysis buffer (pH 7.2)
containing 130 mM NaCl, 10 mM NaH2PO4, 10 mM
Na2HPO4, 0.5% Triton X-100, 0.5% sodium deoxycholate,
2 mM MgCl2, 2.5 U/ml of Benzonase (Merck, Germany)
and EDTA-free protease inhibitor cocktail (Roche,
Switzerland). Homogenate was incubated at 25°C for
30 min for digesting nucleic acids followed by 1,000 g
centrifugation at 4°C for 5 min for removing debris.
Thereafter, 100 μl of supernatant were doubly diluted with
lysis buffer to reach 200 μl of total volume followed by
20 μg/ml of PK-digestion at 37°C for 1 h. The digestion
was stopped by adding 5 mM PMSF (Sigma-Aldrich,
Switzerland) and then the PK-treated supernatants were
transferred into 300 μl of 1 ×QuIC buffer (130 mM NaCl,
5 mM NaH2PO4, 5 mM Na2HPO4 and 1 mM EDTA,
pH 7.4). The total volume reached 500 μl.
The preparations were then brought to equal volume
of buffer containing 20% NaCl and 0.1% sarkosyl. These
solutions were vortexed vigorously followed by incuba-
ting on ice with gentle shaking for 10 min. After centri-
fugation at 16,000 g at 4°C for 10 min, the pellets were
washed by 500 μl of 20 mM Tris–HCl containing 0.05%
sarkosyl followed by 16,000 g of centrifugation at 4°C for
10 min. This washing step was repeated twice. The pellet
was stored at −80°C till being used as the seed.
For preparing the prion seeds, the frozen pellets were
thawed at 4°C followed by washing with 500 μl of
ddH2O. The resuspended solutions were precipitated by
centrifugation at16,000 g for 10 min at 4°C. This step
was repeated twice. The last pellets were resxuspended
thoroughly by 50 μl of ddH2O followed by 1,000 g of
centrifugation at 4°C for 1 min. 45 μl of supernatant
Table 1 The ingredients of qRT-QuIC preparation
Component volume
10 x QuIC buffer
10 μl(100 mM NaH2PO4, 100 mM Na2HPO4,
10 mM EDTA, 1.3 M NaCl, pH 6.9)
dd H2O 35 μl for standard curve, not
for testing tissue extract
3 M NaCl 10 μl
rPrPsen (0.3 mg/ml) 34 μl (final 0.1 mg/ml)
1 mM thioflavin T 1 μl
seed 10 μl for standard curve, 45 μl
for testing tissue extract
total volume of each RT-QuIC 100 μl
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qRT-QuIC to be both the seed and required water. 10 μl
of PrP27-30 with known concentration quantified by
semi-quantitative immunoblotting [17] was used as the
seed for obtaining standard a calibration curve.
PrPC purification
We referred to a published protocol [18] to purify mouse
PrPC. The brain from a healthy 20-week old C57BL/6
mouse was homogenized in chilled 1 × PBS (pH 7.2)
containing EDTA-free protease inhibitor cocktail (Roche,
Switzerland) to make a 10% homogenate (w/v). After cen-
trifugation at 3,000 g at 4°C for 30 min, the pellet was
resuspended with an equal volume of chilled buffer
(pH 7.2) containing 130 mM NaCl, 10 mM NaH2PO4,
10 mM Na2HPO4, 2% NP-40, 1% sodium deoxycholate
and EDTA-free protease inhibitor cocktail (Roche,
Switzerland). After incubation on ice for 30 min, the ho-
mogenate was subjected to 100,000 g centrifugation at 4°C
for 30 min to remove the debris. The supernatant was
filtrated with a 0.22 μm filter (Millipore, USA) followed by
pouring over the ImmunoPure Immobilized Protein A
column (Pierce, USA) to remove the endogenous immu-
noglobulins. The filtrated solution was incubated with
1 ml of Protein A resin cross-link to mouse-PrP specific
monoclonal 4H11 antibody at 4°C over night. Then the
resin was washed with 10 volumes of washing buffer
(20 mM Tris–HCl, 500 mM NaCl and 5 mM EDTA,
pH 8.0) followed by washing with 10 volumes of 1 × PBS
containing 0.5% NP-40. PrPC was eluted with 5 ml of
200 mM glycine. The solution was loaded into 10 kDa fil-
ter centrifugal tubes (Millipore, USA) to centrifuge at
3,000 g at 4°C for 1 h for desalting and buffer exchanging.
Then the protein was resuspended with 5 ml of 1 ×QuIC
buffer and subjected to gel filtration by passing over the
Superdex 75 column (GE lifescience, USA). The harvested
protein in the peak was concentrated with a 10 kDa filter
centrifugal tube (Millipore, USA) followed by estimating
protein concentration with quantitative immunoblot. The
yield of mouse PrPC was approx. 3 μg/brain.
Quantitative RT-QuIC
Preparations for quantitative RT-QuIC were loaded into
a Nunc 96-well plate (Thermo Scientific, USA) in a bio-
safety cabinet. The plate was sealed with transparent
tape for avoiding cross-contamination and aerosol. Reac-
tions were performed on a FLUOstar Optima (BMG
Labtech, Germany) at 37°C for 90 hours with 1 min
shaking at 600 rpm followed by 1 min stationary incuba-
tion. The fluorescence was measured with bottom optic
every hour. Excitation was 440 nm, emission was
480 nm and the gain setting was 2000. Curves and
intersecting lines (for indicating both the threshold and
required hour) were directly shown by the providedfunctions of BMG Optima Data Analysis software. Other
details are shown in the following Method Table 1.
PK-digestion and immunoblot
The 10% brain homogenates of RML- and ME7-infected
mice and purified RML- and ME7-PrP27-30 were digested
with 100 μg/ml of proteinase-K (Roche, Switzerland) at
37°C for 1 h. The digestions were stopped by heating at
100°C for 10 min with 2 × loading buffer. The proteins
were separated in a 15% SDS-PAGE followed by transfer
to a PVDF membrane (Millipore, USA). The membrane
was blocked with 5% non-fat milk for 1 h at room
temperature. The proteins were detected with mouse-
PrP specific 4H11 monoclonal antibody (a gift from E.
Kremmer, National Research Center for Environment
and Health, Munich, Germany). Signals were measured
on a Diana III luminescence imaging system (Raytest,
Germany).
Additional file
Additional file 1: Figure S1. Determining the time-span of qRT-QuIC.
RT-QuIC reactions were seeded with PrP27-30 or PrPC with the indicated
amounts. A non-seeded reaction was performed as the control. After
130 h at 37°C, both PrPC-seeded and non-seeded reactions showed rising
curves, indicating that the spontaneous conversion started at approx.
100 h. Therefore, we chose 90 hours as the maximum time-span of
monitoring prion conversion in the qRT-QuIC system. Figures S2 and S3:
Detecting seeded PrP27-30 with RT-QuIC. Purified RML and ME7 PrP27-30
and control PrPC with the quantities from 10-10 to 10-16 g were seeded
into reactions independently to perform 90 h of RT-QuIC at 37°C. Figure
S4: The positive RT-QuIC reactions seeded with PrP27-30 (10-10 to 10-15.5 g
for RML and 10-10 to 10-16 g for ME7) within 90 h are shown. Each scale
on the Y-axis represents one effective reaction, the X-axis indicates the
required hours corresponding to the reaction. The reactions seeded with
10-16 g of RML PrP27-30 were negative up to 90 h and thus are not shown
in the figure. Table S1: Comparing PrP27-30 concentrations measured by
quantitative RT-QuIC and quantitative immunoblot. Table S2: The
concentration of PrP27-30 in 7 tissues from RML scrapie-infected mice of 7
time-points. Table S3: The concentration of PrP27-30 in 7 tissues from
ME7 scrapie-infected mice of 6 time-points.
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